63 related articles for article (PubMed ID: 7976384)
1. [Pharmacokinetics and pharmacodynamics of slow release tablet of diltiazem in hypertensive patients with various renal functions].
Chen SX; Gu TH; Song DJ; Guo JZ; Wang XM; Gong LS
Zhongguo Yao Li Xue Bao; 1994 May; 15(3):263-6. PubMed ID: 7976384
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and pharmacodynamics of nisoldipine in hypertensive patients with normal and mild to moderate impaired renal function.
Shionoiri H; Minamisawa K; Masumori S; Satta H; Minamisawa M; Takizawa T; Jinno Y; Takeda K; Nagasawa T; Takasaki I
Arzneimittelforschung; 1995 Jul; 45(7):785-9. PubMed ID: 8573223
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and pharmacodynamics of the alpha 1-adrenergic antagonist bunazosin retard in hypertensives.
Shionoiri H; Minamisawa M; Ueda S; Minamisawa K; Takizawa T; Takasaki I; Sugimoto K; Gotoh E; Ishii M
Arzneimittelforschung; 1994 Nov; 44(11):1191-5. PubMed ID: 7848330
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacokinetics and pharmacodynamics of diltiazem floating tablets].
Gu TH; Chen SX; Zhu JB; Song DJ; Guo JZ; Hou HM
Zhongguo Yao Li Xue Bao; 1992 Nov; 13(6):527-31. PubMed ID: 1302441
[TBL] [Abstract][Full Text] [Related]
5. Effect of renal function on the pharmacokinetics and pharmacodynamics of trandolapril.
Bevan EG; McInnes GT; Aldigier JC; Conte JJ; Grunfeld JP; Harper SJ; Meyer BH; Pauly N; Wilkinson R
Br J Clin Pharmacol; 1993 Feb; 35(2):128-35. PubMed ID: 8443030
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of enalapril/diltiazem ER in hypertensive patients with coexisting renal dysfunction. Enalapril/Diltiazem ER in Hypertensive Renal Disease Group.
Hricik DE; Levine BS; Adrogue HJ; Weinberg MS; Goldstein R
J Hum Hypertens; 1996 Nov; 10(11):769-74. PubMed ID: 9004108
[TBL] [Abstract][Full Text] [Related]
7. [Prevention of diltiazem in tacrolimus-induced nephrotoxicity: experiment with rats].
Chen YH; Liang YX; Chen LQ; Liang JJ; Zhang J; Qiu J; Li WL; Hu JB; Xie KJ; Zhong WD; Chen LZ; Zheng KL
Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2235-7. PubMed ID: 18001539
[TBL] [Abstract][Full Text] [Related]
8. Multicenter studies on the pharmacokinetic profile of sustained-release oral diltiazem (300 mg) after once a day repeated administration: influence of age.
Bianchetti G; Billy S; Ascalone V; Saivin S; Houin G; Rosenzweig P
Int J Clin Pharmacol Ther; 1996 May; 34(5):195-201. PubMed ID: 8738855
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of the tolerance and effectiveness of Diltiazem LP 300 mg in hypertensive patients with chronic renal insufficiency].
Bernadet-Monrozies P; Poilleux E; Suc JM
Ann Cardiol Angeiol (Paris); 1998 Oct; 47(8):589-94. PubMed ID: 9809145
[TBL] [Abstract][Full Text] [Related]
10. Renal effects of prolonged antihypertensive treatment with diltiazem.
Tramonti G; Donadio C; Silvestri L; Caputo M; Lucchetti A; Giordani R; Bianchi C
Kidney Int Suppl; 1996 Jun; 55():S78-80. PubMed ID: 8743517
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic and pharmacodynamic interactions between simvastatin and diltiazem in patients with hypercholesterolemia and hypertension.
Watanabe H; Kosuge K; Nishio S; Yamada H; Uchida S; Satoh H; Hayashi H; Ishizaki T; Ohashi K
Life Sci; 2004 Dec; 76(3):281-92. PubMed ID: 15531380
[TBL] [Abstract][Full Text] [Related]
12. Diltiazem concentrations in plasma vs PR intervals on electrocardiogram in 8 men.
Liu XD; Xie L; Zhong B; Xu Q; Luan LB; Liu GQ
Zhongguo Yao Li Xue Bao; 1996 Sep; 17(5):411-4. PubMed ID: 9863161
[TBL] [Abstract][Full Text] [Related]
13. [Nephrotoxicity of tacrolimus and preventive effect of diltiazem: experiment with rats].
Chen YH; Liang YX; Chen LQ; Lu YM; Liang JJ; Zhang J; Qiu J; Xie KJ; Hu JB; Zhong WD; Wang B; Chen LZ; Zheng KL
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):704-8. PubMed ID: 19595068
[TBL] [Abstract][Full Text] [Related]
14. Pentostatin pharmacokinetics and dosing recommendations in patients with mild renal impairment.
Lathia C; Fleming GF; Meyer M; Ratain MJ; Whitfield L
Cancer Chemother Pharmacol; 2002 Aug; 50(2):121-6. PubMed ID: 12172976
[TBL] [Abstract][Full Text] [Related]
15. PK/PD modelling of high-dose diltiazem--absorption-rate dependency of the hysteresis loop.
Luckow V; Della Paschoa O
Int J Clin Pharmacol Ther; 1997 Oct; 35(10):418-25. PubMed ID: 9352390
[TBL] [Abstract][Full Text] [Related]
16. Diltiazem modulates cyclosporin A induced renal hemodynamic effects but not its effect on plasma endothelin-1.
Asberg A; Christensen H; Hartmann A; Berg KJ
Clin Transplant; 1998 Oct; 12(5):363-70. PubMed ID: 9787942
[TBL] [Abstract][Full Text] [Related]
17. [Spirapril - a new long-acting ACE inhibitor: efficacy and safety in patients with arterial hypertension in combination with diabetes mellitus and impaired kidney function].
Iakusevich VV; Mozheĭko ME; Paliutin ShKh; Berezina MIu; Martsevich SIu; Shal'nova SA; Deev AD; Kutishenko NP; Alimova EV; Koniakhina IP; Semenova IuE
Ter Arkh; 2000; 72(10):82-6. PubMed ID: 11220887
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and pharmacodynamics of lobaplatin (D-19466) in patients with advanced solid tumors, including patients with impaired renal of liver function.
Welink J; Boven E; Vermorken JB; Gall HE; van der Vijgh WJ
Clin Cancer Res; 1999 Sep; 5(9):2349-58. PubMed ID: 10499604
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic and pharmacodynamic interactions between diltiazem and methylprednisolone in healthy volunteers.
Booker BM; Magee MH; Blum RA; Lates CD; Jusko WJ
Clin Pharmacol Ther; 2002 Oct; 72(4):370-82. PubMed ID: 12386639
[TBL] [Abstract][Full Text] [Related]
20. Long-term effects of diltiazem and atenolol on blood glucose, serum lipids, and serum urate in hypertensive patients. Swedish-Finnish Study Group.
Thulin T; Lehtonen A; Dahlöf C; Nilsson-Ehle P; Engqvist L; Lagerstedt C; Berglund E
Int J Clin Pharmacol Ther; 1999 Jan; 37(1):28-33. PubMed ID: 10027480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
